Novartis Institutes for BioMedical Research
GPTKB entity
Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:research_institute
|
| gptkbp:abbreviation |
gptkb:NIBR
|
| gptkbp:focus |
biomedical research
drug discovery |
| gptkbp:foundedBy |
gptkb:Novartis
|
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Novartis Institutes for BioMedical Research
|
| gptkbp:industry |
gptkb:biotechnology
pharmaceuticals |
| gptkbp:leader |
Fiona H. Marshall
|
| gptkbp:leaderTitle |
President
|
| gptkbp:location |
gptkb:Shanghai,_China
gptkb:Singapore gptkb:Basel,_Switzerland gptkb:Emeryville,_California,_United_States gptkb:East_Hanover,_New_Jersey,_United_States |
| gptkbp:mission |
discover new medicines to improve and extend people’s lives
|
| gptkbp:parentOrganization |
gptkb:Novartis
|
| gptkbp:partOf |
Novartis Global Drug Development organization
|
| gptkbp:website |
https://www.nibr.com/
|
| gptkbp:bfsParent |
gptkb:Route_128_corridor
gptkb:Kendall_Square,_Cambridge,_Massachusetts |
| gptkbp:bfsLayer |
7
|